Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 13, 2018
[China National Lung Cancer Screening Guideline with Low-dose Computed 
Tomography (2018 version)]Qinghua Zhou, Yaguang Fan, Ying Wang, et al.
International Journal of Cancer|December 31, 2025
Five-year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non-small-cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE-042 China studyYi-Long Wu, Li Zhang, Yun Fan, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
MicroRNA Expression Profiles of Epicardial Adipose Tissue-Derived Exosomes in Patients with Coronary AtherosclerosisJinxing Liu, Ang Gao, Yan Liu, et al.
Cancer Biology & Medicine|October 1, 2019
Prevalence and clinical significance of pathogenic germline <i>BRCA1</i>/<i>2</i> mutations in Chinese non-small cell lung cancer patientsXingsheng Hu, Dongyong Yang, Yalun Li, et al.
International Journal of Cancer|November 24, 2020
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer: KEYNOTE-042 China StudyYi-Long Wu, Li Zhang, Yun Fan, et al.
JTO Clinical and Research Reports|October 18, 2021
Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407Ying Cheng, Li Zhang, Jie Hu, et al.
BMC Cancer|April 11, 2016
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancerYan Sun, Ying Cheng, Xuezhi Hao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2015
A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancerShun Lu, Lu Li, Yi Luo, et al.
Experimental Cell Research|July 1, 2019
NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarizationChao Song, Haitao Li, Yi Li, et al.
The Lancet. Respiratory Medicine|July 24, 2017
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trialJin-Ji Yang, Caicun Zhou, Yisheng Huang, et al.
Pageof 25